AMBIT BIOSCIENCES CORP's ticker is AMBI and the CUSIP is 02318X100. A total of 49 filers reported holding AMBIT BIOSCIENCES CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $2,277,000 | -54.9% | 329,460 | -40.5% | 0.17% | -55.6% |
| Q1 2014 | $5,051,000 | -1.3% | 553,843 | +4.3% | 0.38% | -12.6% |
| Q4 2013 | $5,118,000 | -44.8% | 530,861 | -11.3% | 0.44% | -42.7% |
| Q3 2013 | $9,274,000 | +112.8% | 598,300 | -3.9% | 0.76% | +99.7% |
| Q2 2013 | $4,358,000 | – | 622,500 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 2,079,569 | $14,370,000 | 12.05% |
| Aisling Capital LLC | 1,650,156 | $11,400,000 | 3.30% |
| GREAT POINT PARTNERS LLC | 1,053,895 | $7,282,000 | 3.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 277,568 | $1,918,000 | 0.47% |
| WEXFORD CAPITAL LP | 329,460 | $2,277,000 | 0.17% |
| Eventide Asset Management | 151,100 | $1,044,000 | 0.14% |
| Orbimed Advisors | 1,490,769 | $10,301,000 | 0.12% |
| Gruss Capital Management LP | 357,492 | $2,470,000 | 0.12% |
| BAILARD, INC. | 93,000 | $643,000 | 0.10% |
| Artal Group S.A. | 250,000 | $1,728,000 | 0.07% |